These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37243721)

  • 1. Clinical characteristics and associated factors of qualitative olfactory dysfunction.
    Eo TS; Lee HY; Cho HJ; Yoon JH; Rha MS; Kim CH
    Rhinology; 2023 Oct; 61(5):432-440. PubMed ID: 37243721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Patient Characteristics and Olfactory Sensitivity for Trigger Odorants in Parosmia and Phantosmia.
    Sekine R; Hernandez AK; Overbeck C; Hofer MK; Mori E; Hähner A; Hummel T
    Laryngoscope; 2024 Jul; 134(7):3277-3285. PubMed ID: 38578016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parosmia in patients with post-infectious olfactory dysfunction in the era of COVID-19-associated olfactory impairment.
    Gunder N; Hummel T
    HNO; 2024 Sep; 72(9):649-656. PubMed ID: 38935276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Qualitative smell/taste disorders as sequelae of acute COVID-19.
    Ercoli T; Masala C; Pinna I; Orofino G; Solla P; Rocchi L; Defazio G
    Neurol Sci; 2021 Dec; 42(12):4921-4926. PubMed ID: 34557966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Parosmia and phantosmia: clinical update].
    Macario S; Hsieh JW; Daskalou D; Voruz F; Landis BN
    Rev Med Suisse; 2022 Oct; 18(798):1837-1842. PubMed ID: 36200960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and correlates of parosmia and phantosmia among smell disorders.
    Pellegrino R; Mainland JD; Kelly CE; Parker JK; Hummel T
    Chem Senses; 2021 Jan; 46():. PubMed ID: 34698820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study on the prognostic significance of qualitative olfactory dysfunction.
    Reden J; Maroldt H; Fritz A; Zahnert T; Hummel T
    Eur Arch Otorhinolaryngol; 2007 Feb; 264(2):139-44. PubMed ID: 17006637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Qualitative Olfactory Dysfunction and COVID-19: An Evidence-Based Review with Recommendations for the Clinician.
    Gary JB; Gallagher L; Joseph PV; Reed D; Gudis DA; Overdevest JB
    Am J Rhinol Allergy; 2023 Jan; 37(1):95-101. PubMed ID: 35957578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Well-being in patients with olfactory dysfunction.
    Mai Y; Menzel S; Cuevas M; Haehner A; Hummel T
    Physiol Behav; 2022 Oct; 254():113899. PubMed ID: 35809697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parosmia and Phantosmia: Managing Quality Disorders.
    Altundag A
    Curr Otorhinolaryngol Rep; 2023; 11(1):19-26. PubMed ID: 36721659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Features of Parosmia Associated With COVID-19 Infection.
    Lerner DK; Garvey KL; Arrighi-Allisan AE; Filimonov A; Filip P; Shah J; Tweel B; Del Signore A; Schaberg M; Colley P; Govindaraj S; Iloreta AM
    Laryngoscope; 2022 Mar; 132(3):633-639. PubMed ID: 34870334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parosmia Is Positively Associated With Problematic Drinking, as Is Phantosmia With Depressive Symptoms.
    Agarwal K; Luk JW; Stangl BL; Schwandt ML; Momenan R; Goldman D; Diazgranados N; Kareken DA; Leggio L; Ramchandani VA; Joseph PV
    J Addict Med; 2024 Sep-Oct 01; 18(5):567-573. PubMed ID: 38776446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olfactory-related Quality of Life Adjustments in Smell Loss during the Coronavirus-19 Pandemic.
    Liu DT; Prem B; Besser G; Renner B; Mueller CA
    Am J Rhinol Allergy; 2022 Mar; 36(2):253-260. PubMed ID: 34704454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proof-of-concept: SCENTinel 1.1 rapidly discriminates COVID-19-related olfactory disorders.
    Hunter SR; Hannum ME; Pellegrino R; O'Leary MA; Rawson NE; Reed DR; Dalton PH; Parma V
    Chem Senses; 2023 Jan; 48():. PubMed ID: 36796784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical factors associated with lower health scores in COVID-19-related persistent olfactory dysfunction.
    Said M; Luong T; Jang SS; Davis ME; DeConde AS; Yan CH
    Int Forum Allergy Rhinol; 2022 Oct; 12(10):1242-1253. PubMed ID: 35032409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phantom smells: a prevalent COVID-19 symptom that progressively sets in.
    Bousquet C; Bouchoucha K; Bensafi M; Ferdenzi C
    Eur Arch Otorhinolaryngol; 2023 Mar; 280(3):1219-1229. PubMed ID: 36173444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trigeminal function in patients with COVID-associated olfactory loss.
    Juratli JH; Garefis K; Konstantinidis I; Hummel T
    Eur Arch Otorhinolaryngol; 2024 May; 281(5):2403-2411. PubMed ID: 38127097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olfactory distortions in the general population.
    Olofsson JK; Ekesten F; Nordin S
    Sci Rep; 2022 Jun; 12(1):9776. PubMed ID: 35697904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the clinical usefulness of structured questions in parosmia assessment.
    Landis BN; Frasnelli J; Croy I; Hummel T
    Laryngoscope; 2010 Aug; 120(8):1707-13. PubMed ID: 20641087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-lasting olfactory dysfunction in COVID-19 patients.
    Prem B; Liu DT; Besser G; Sharma G; Dultinger LE; Hofer SV; Matiasczyk MM; Renner B; Mueller CA
    Eur Arch Otorhinolaryngol; 2022 Jul; 279(7):3485-3492. PubMed ID: 34757458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.